Programming the lifestyles of engineered bacteria for cancer therapy

被引:24
|
作者
Fu, Shengwei [1 ]
Zhang, Rongrong [2 ]
Gao, Yanmei [1 ]
Xiong, Jiarui [1 ]
Li, Ye [2 ]
Pu, Lu [3 ]
Xia, Aiguo [2 ]
Jin, Fan [1 ,2 ]
机构
[1] Univ Sci & Technol China, Hefei Natl Res Ctr Phys Sci Microscale, Dept Polymer Sci & Engn, Hefei 230026, Peoples R China
[2] Chinese Acad Sci, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol, CAS Key Lab Quantitat Engn Biol, Shenzhen 518055, Peoples R China
[3] Sichuan Univ, West China Sch Med, West China Hosp, Chengdu 610065, Peoples R China
关键词
genetic engineering; drug delivery; cancer therapy; optogenetics; synthetic biology; ATTENUATED SALMONELLA-TYPHIMURIUM; PSEUDOMONAS-AERUGINOSA; TUMOR MICROENVIRONMENT; BIOFILM FORMATION; EFFICACY; DELIVERY; RESISTANCE; MOTILITY; LIGHT; MODEL;
D O I
10.1093/nsr/nwad031
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Programming intratumoral bacterial life style transitions allow precise control of multiple key steps throughout the bacteria-mediated cancer therapy process and therapeutic efficacy can be greatly improved by controlling the localization and dosage of therapeutic agents via optimizing the illumination scheme. Bacteria can be genetically engineered to act as therapeutic delivery vehicles in the treatment of tumors, killing cancer cells or activating the immune system. This is known as bacteria-mediated cancer therapy (BMCT). Tumor invasion, colonization and tumor regression are major biological events, which are directly associated with antitumor effects and are uncontrollable due to the influence of tumor microenvironments during the BMCT process. Here, we developed a genetic circuit for dynamically programming bacterial lifestyles (planktonic, biofilm or lysis), to precisely manipulate the process of bacterial adhesion, colonization and drug release in the BMCT process, via hierarchical modulation of the lighting power density of near-infrared (NIR) light. The deep tissue penetration of NIR offers us a modality for spatio-temporal and non-invasive control of bacterial genetic circuits in vivo. By combining computational modeling with a high-throughput characterization device, we optimized the genetic circuits in engineered bacteria to program the process of bacterial lifestyle transitions by altering the illumination scheme of NIR. Our results showed that programming intratumoral bacterial lifestyle transitions allows precise control of multiple key steps throughout the BMCT process and therapeutic efficacy can be greatly improved by controlling the localization and dosage of therapeutic agents via optimizing the illumination scheme.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Environmentally controlled invasion of cancer cells by engineered bacteria
    Anderson, JC
    Clarke, EJ
    Arkin, AP
    Voigt, CA
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 355 (04) : 619 - 627
  • [22] Tumour-targeting bacteria engineered to fight cancer
    Shibin Zhou
    Claudia Gravekamp
    David Bermudes
    Ke Liu
    Nature Reviews Cancer, 2018, 18 : 727 - 743
  • [23] Tumour-targeting bacteria engineered to fight cancer
    Zhou, Shibin
    Gravekamp, Claudia
    Bermudes, David
    Liu, Ke
    NATURE REVIEWS CANCER, 2018, 18 (12) : 727 - 743
  • [24] Injectable microgels containing genetically engineered bacteria for colon cancer therapy through programmed Chemokine expression
    Chen, Yazhou
    Cai, Kehan
    Zhao, Hui
    Li, Wenshuai
    Gao, Xiaofang
    Fu, Yinzheng
    Lee, Kyubae
    Li, SiTian
    Yao, Shengjie
    Chen, Tao
    MATERIALS TODAY BIO, 2024, 29
  • [25] Ultrasound-controllable engineered bacteria for cancer immunotherapy
    Abedi, Mohamad H.
    Yao, Michael S.
    Mittelstein, David R.
    Bar-Zion, Avinoam
    Swift, Margaret B.
    Lee-Gosselin, Audrey
    Barturen-Larrea, Pierina
    Buss, Marjorie T.
    Shapiro, Mikhail G.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [26] Commentary - Can engineered bacteria help control cancer?
    Jain, RK
    Forbes, NS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) : 14748 - 14750
  • [27] Engineered T Cells for Cancer Therapy
    June, Carl H.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 945 - 945
  • [28] Engineered Salmonella typhimurium as a Cancer Therapy
    Pacher-Zavisin, Margit C.
    BIOENGINEERED, 2017, 8 (03) : 192 - 192
  • [29] Engineered T cells for cancer therapy
    June, Carl H.
    Maus, Marcela V.
    Plesa, Gabriela
    Johnson, Laura A.
    Zhao, Yangbing
    Levine, Bruce L.
    Grupp, Stephan A.
    Porter, David L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (09) : 969 - 975
  • [30] Engineered Hydrogels in Cancer Therapy and Diagnosis
    Sepantafar, Mohammadmajid
    Maheronnaghsh, Reihan
    Mohammadi, Hossein
    Radmanesh, Fatemeh
    Hasani-Sadrabadi, Mohammad Mahdi
    Ebrahimi, Marzieh
    Baharvand, Hossein
    TRENDS IN BIOTECHNOLOGY, 2017, 35 (11) : 1074 - 1087